Oak Ridge Investments’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-30,451
| Closed | -$5.24M | – | 188 |
|
|
2021
Q3 | $5.24M | Sell |
30,451
-1,244
| -4% | -$163K | 0.46% | 73 |
|
|
2021
Q2 | $3.98M | Sell |
31,695
-1,239
| -4% | -$156K | 0.35% | 96 |
|
|
2021
Q1 | $4.47M | Sell |
32,934
-1,310
| -4% | -$169K | 0.42% | 90 |
|
|
2020
Q4 | $4.38M | Sell |
34,244
-9,013
| -21% | -$1.06M | 0.39% | 95 |
|
|
2020
Q3 | $4.87M | Sell |
43,257
-3,016
| -7% | -$300K | 0.38% | 94 |
|
|
2020
Q2 | $4.41M | Sell |
46,273
-3,537
| -7% | -$341K | 0.37% | 93 |
|
|
2020
Q1 | $4.48M | Buy |
+49,810
| New | +$3.87M | 0.46% | 84 |
|
|
2017
Q3 | – | Sell |
-127,589
| Closed | -$3.88M | – | 172 |
|
|
2017
Q2 | $3.88M | Buy |
127,589
+2,666
| +2% | +$77.3K | 0.12% | 112 |
|
|
2017
Q1 | $3.31M | Sell |
124,923
-877,411
| -88% | -$23.1M | 0.11% | 106 |
|
|
2016
Q4 | $25.6M | Sell |
1,002,334
-224,134
| -18% | -$7.1M | 0.83% | 47 |
|
|
2016
Q3 | $44.4M | Sell |
1,226,468
-115,363
| -9% | -$3.82M | 1.15% | 35 |
|
|
2016
Q2 | $45.6M | Sell |
1,341,831
-163,818
| -11% | -$5.33M | 1.17% | 31 |
|
|
2016
Q1 | $39.7M | Sell |
1,505,649
-17,318
| -1% | -$504K | 1% | 41 |
|
|
2015
Q4 | $74.3M | Sell |
1,522,967
-2,214
| -0.1% | -$79.7K | 1.78% | 18 |
|
|
2015
Q3 | $38M | Buy |
1,525,181
+119,942
| +9% | +$3.6M | 0.91% | 40 |
|
|
2015
Q2 | $44.5M | Buy |
1,405,239
+242,914
| +21% | +$7.84M | 0.94% | 41 |
|
|
2015
Q1 | $44.2M | Buy |
1,162,325
+477,389
| +70% | +$19M | 0.99% | 36 |
|
|
2014
Q4 | $26.7M | Buy |
684,936
+611,585
| +834% | +$21.3M | 0.64% | 52 |
|
|
2014
Q3 | $2.22M | Buy |
+73,351
| New | +$2.07M | 0.06% | 128 |
|
Oak Ridge Investments's XLRN Position: Q4 2021 in Review
Oak Ridge Investments sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 30,451 shares — an estimated $5.24M sold.
Oak Ridge Investments first reported a position in XLRN in Q3 2014 and held it in 19 quarters. The position peaked at $74.3M in Q4 2015. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Oak Ridge Investments reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Oak Ridge Investments sold 30,451 Acceleron Pharma shares in Q4 2021, an estimated $5.24M.
- Oak Ridge Investments first reported a position in Acceleron Pharma in Q3 2014 and held it in 19 quarters.
- Oak Ridge Investments's Acceleron Pharma position peaked at $74.3M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Oak Ridge Investments's 13F filing for Q4 2021, filed 1 Feb 2022.